• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Monthly, March 2017

The CenterWatch Monthly, March 2017

March 1, 2017
CenterWatch Staff

Novo Nordisk, Servier, Otsuka, Teva among top sponsors

Sponsors have done a good job of main­taining, but not improving, the overall quality of their relationships with in­vestigative sites during the past two years, according to a new CenterWatch survey, but performance gaps have widened across sev­eral of the attributes sites identify as the most important for conducting a successful study. Leading sponsor companies have made strengthening their relationships with inves­tigative sites a top priority in recent years and have created a wide range of initiatives de­signed to incorporate investigator viewpoints into improving clinical development process­es and easing site burdens. The 2017 CenterWatch Global Investigative Site Survey suggests that investigators have raised their expectations for sponsor perfor­mance in providing better study support, good protocol design and easily accessible staff as in­vestigators face increasing compliance, regula­tory and financial pressures when conducting clinical trials.

Sites wrestle with protocol design complexity

The growing complexity of protocols is re­sulting in longer cycle times, rising costs and increased pressures on staff and patients throughout the clinical trial process. Tufts Center for the Study of Drug Develop­ment (CSDD) studies have found that the num­ber of endpoints, procedures and eligibility criteria of typical phase III protocols increased significantly during 2002-2012, and have con­tinued to grow. These factors combine to in­crease costs and burdens on research teams.

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing